SDGR.US Schrodinger Inc

Healthcare Health Care Technology USA Stocks
29.23 USD
Close of Nov 18, 2026
10.95 34.00
Market cap
USD 1.93B
P/E
-
P/B
6.81x
ROE
-40.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SDGR.US undervalued?

Graham number

The Graham number of Schrodinger Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Schrodinger Inc fundamental analysis

No fundamental analysis for Schrodinger Inc yet.

Schrodinger Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug D…

Full company profile